logo
LIBOGENE is in the business of cancer molecular diagnosis. The company has established an internationally certified CAP laboratory, and is building a tumor mutant gene databank. LIBOGENE has successfully developed many targeted cancer treatment testing panels and identified novel indigenous tumor resistant gene mutations which can be used as important diagnostic biomarkers.
If you have any questions about our products and services, please input the following details, we will contact you as soon as possible to answer your questions.

繁中  |  简中  |  ENG
 

FAQ

LIBOGENE is professional and provides the best service

Genetic mutation

Q:WHAT IS GENETIC MUTATION AND HOW DOES IT CAUSE CANCER?

Genetic mutation is a change in the DNA sequence in a cell. Any changes to the DNA can severely affect cell function or cause the occurrence of diseases. Cancer is a type of disease caused by genetic mutation. When genes related to cell growth, division or death mutates, these changes can cause cancer. That is, when a normal cell gene mutates, it can change into cancerous cells. These cells multiply at abnormal speeds and can spread to other body parts.

Q: WHAT IS TARGETED THERAPY?

Targeted therapy is a general term that refers to treatment directed at specific molecules in cancer cells. The function of these drugs is to interrupt cancer cell division and growth. During the treatment period, division and growth of normal cells will also be affected by drugs, which can cause side effects.

Test items

Q:I WANT TO KNOW MORE ABOUT YOUR COMPANY’S CANCER GENETIC TESTING SERVICE. HOW DO I PROCEED?

A designated staff will provide you with information on the testing service. You can discuss the testing first with your attending physician and have the physician evaluate whether you require this type of testing. If necessary, we will determine whether your current hospital can conduct the followed specimen shipping. Our professional staff can also provide a complete introduction to your attending physician.

Q:WHAT TESTS ARE BEING DONE? CAN ANYONE DO THEM?

Because this test requires a tumor specimen, this test is for patients who have been diagnosed with cancer. The genetic test report can help doctors determine the most appropriate targeted drug for the patient.

Test methods

Q:HOW DO I PROCEED WITH THIS TEST?

You can discuss with your attending physician and have him/her evaluate whether you need this test. Our professional staff can also provide information to your attending physician.

Q:HOW MUCH IS THE COST OF YOUR TESTS?

The cost can vary depending on your test items. You can discuss the tests with your attending physician. Our professional staff can also provide information to your attending physician to make sure that you need the test items.

Q:HOW IS THIS TEST DONE, DO YOU NEED TO DRAW BLOOD?

This depends on your diagnostic requirements. Blood specimen or tumor cell biopsy are done based on the tests required. Our staff will communicate and discuss this with your attending physician.

Q: CAN I SKIP REGISTERING AT THE HOSPITAL AND GO DIRECTLY TO YOUR COMPANY FOR THE TESTS?

You can make inquiries with our company staff and we will explain the process to you, as well as help you with the tests.

Q: MY CANCER HAS METASTASIZED, IS THE GENETIC TESTS RELATED TO SPECIFIC CANCER TYPE?

LIBOGENE can analyze any types of tumors, regardless of where it is in the body or how the cancer is progressing. As long as there are specimens, we can analyze them. It is best for you to consult your clinical doctor before you proceed with genetic testing.

Q:IF THE PATHOLOGICAL SECTION IS OVER SIX MONTHS OR ONE YEAR OLD, CAN IT STILL BE USED?

This must be assessed by the pathologist.

Report analysis

Q:WHEN CAN I GET MY REPORT? HOW DO I GET MY REPORT?

Our normal testing time is 5 – 10 working days. Once the test is complete, the report will be given to your attending doctor. You just have to register as you would normal at your hospital to see your doctor.

Q:WHAT HAPPENS AFTER MY TEST IS COMPLETE? WILL I KNOW WHAT DRUGS TO TAKE?

Once we have completed the test report, we will transfer the report to your attending doctor. As for the details of your follow-up treatment, your attending doctor will make the determination.